Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.SummaryDifference0.3%

- Check28 days agoChange DetectedNotice about government funding and operating status has been removed. The removal does not affect the study details, eligibility criteria, or results.SummaryDifference0.2%

- Check42 days agoChange DetectedNo significant additions or deletions to core content were observed on the Study Details page; the main sections (Overview, Eligibility, Plan, Locations) remain as before.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a prominent operating-status notice and a new software version (v3.2.0), replacing the old version tag v3.1.0. This signals potential delays in data processing and updated status information.SummaryDifference2%

- Check78 days agoChange DetectedUpdate location name from Blankenfelde to Blankenfelde-Mahlow and bump revision from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.SummaryDifference0.1%

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.